Template:Available forms of testosterone
Jump to navigation
Jump to search
Template documentation
| Route | Ingredient | Form | Dose[lower-alpha 2] | Brand names[lower-alpha 3] | |
|---|---|---|---|---|---|
| Oral | Template:No selflink | Capsule | 40 mg | Andriol, Jatenzo | |
| Sublingual | Template:No selflink | Tablet | 10 mg | Testoral | |
| Buccal | Template:No selflink | Tablet | 30 mg | Striant | |
| Intranasal | Template:No selflink | Nasal gel | 5.5 mg/spray, 120 sprays | Natesto | |
| Transdermal | Template:No selflink | Non-scrotal patch | 2.5, 4, 5, 6 mg/day | Androderm | |
| Non-scrotal patch | 150, 300 μg/day | Intrinsa | |||
| Scrotal patch[lower-alpha 4] | 4, 6 mg/day | Testoderm | |||
| Topical gel | 25, 50, 75, 100, 125 mg/pump | AndroGel, Testim | |||
| Axillary solution | 30 mg/pump | Axiron | |||
| Rectal | Template:No selflink | Suppository | 40 mg | Rektandron | |
| Injection[lower-alpha 5] | Template:No selflink | Oil solution | 50, 100, 180, 200, 250 mg/mL | Delatestryl | |
| Template:No selflink | Oil solution | 50, 100, 200, 250 mg/mL | Depo-Testosterone | ||
| Template:No selflink[lower-alpha 6] | Oil solution | 100, 250 mg/mL | Sustanon | ||
| Template:No selflink | Oil solution | 750, 1000 mg | Aveed, Nebido | ||
| Implant | Template:No selflink | Pellet | 50, 75, 100, 200 mg | Testopel | |
See also
- Testosterone (medication) § Available forms
- Pharmacokinetics of testosterone § Routes of administration
- Template:Available forms of estradiol
- Template:Available forms of progesterone
References
- ↑ Nieschlag E (September 2006). "Testosterone treatment comes of age: new options for hypogonadal men". Clin. Endocrinol. (Oxf). 65 (3): 275–81. doi:10.1111/j.1365-2265.2006.02618.x. PMID 16918944.
- ↑ Nieschlag E (January 2015). "Current topics in testosterone replacement of hypogonadal men". Best Pract. Res. Clin. Endocrinol. Metab. 29 (1): 77–90. doi:10.1016/j.beem.2014.09.008. PMID 25617174.
- ↑ Byrne M, Nieschlag E (May 2003). "Testosterone replacement therapy in male hypogonadism". J. Endocrinol. Invest. 26 (5): 481–9. doi:10.1007/bf03345206. PMID 12906378.
- ↑ M. Cappa; S. Cianfarani; L. Ghizzoni; S. Loche, M. Maghnie (10 December 2015). Advanced Therapies in Pediatric Endocrinology and Diabetology: Workshop, Rome, October 2014. Karger Medical and Scientific Publishers. pp. 68–. ISBN 978-3-318-05637-2.
- ↑ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.
- ↑ Shlomo Melmed (1 January 2016). Williams Textbook of Endocrinology. Elsevier Health Sciences. pp. 760–769. ISBN 978-0-323-29738-7.
- ↑ Patrick Lenehan (12 June 2003). Anabolic Steroids. CRC Press. pp. 108–109. ISBN 978-0-415-28029-7.
- ↑ Becker, Kenneth L. (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 1116, 1119, 1152, 1182–1185, 1195–1197, 2146. ISBN 978-0-7817-1750-2. Archived from the original on May 5, 2017. Unknown parameter
|name-list-style=ignored (help) - ↑ Nieschlag, Eberhart; Behre, Hermann M. (6 December 2012). Testosterone: Action - Deficiency - Substitution. Springer Science & Business Media. pp. 1–, 9, 298, 309–331, 349–353, 366–367. ISBN 978-3-642-72185-4. Unknown parameter
|name-list-style=ignored (help) - ↑ Krishna; Usha R. And Shah (1996). Menopause. Orient Blackswan. pp. 70–. ISBN 978-81-250-0910-8.
- ↑ Janet Brotherton (1976). Sex Hormone Pharmacology. Academic Press. pp. 18–19, 331, 336. ISBN 978-0-12-137250-7.
- ↑ Barbara G. Wells; Joseph T. DiPiro; Terry L. Schwinghammer; Cecily V. DiPiro (22 August 2014). Pharmacotherapy Handbook, 9/E. McGraw-Hill Education. p. 288. ISBN 978-0-07-182129-2.
- ↑ Lauritzen, Christian (1988). "Natürliche und Synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien" [Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles]. In Hermann P. G. Schneider; Christian Lauritzen; Eberhard Nieschlag (eds.). Grundlagen und Klinik der Menschlichen Fortpflanzung [Foundations and Clinic of Human Reproduction] (in German). Walter de Gruyter. pp. 229–306. ISBN 978-3110109689. OCLC 35483492.
- ↑ Apotekens informationsavdelning (1964). Apotekens synonymregister över farmacevtiska specialiteter. Apotekens informationsavdelning.
Rektandron FERRING supp. 40 mg • individ. dos. • 10 st.
| Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages. Subpages of this template. |
Cite error: <ref> tags exist for a group named "lower-alpha", but no corresponding <references group="lower-alpha"/> tag was found, or a closing </ref> is missing